Anmeldung erfolgt in Kürze...
Details werden geladen...
SpyGlass Pharma Q3 Loss Widens | 11.11.26 | finanzen.at
(RTTNews) - SpyGlass Pharma, Inc. (SGP), a late-stage biopharmaceutical company focused on chronic eye conditions, reported wider third-quarter lo...
Ähnliche Seiten
SpyGlass Pharma Q3 Loss Widens | 11.11.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/spyglass-pharma-q3-loss-widens-1036751795
Inhibrx Q3 Loss Widens | 13.11.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/inhibrx-q3-loss-widens-1036763472Inhibrx Q3 Loss Widens | 13.11.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/inhibrx-q3-loss-widens-1036763472Equillium Q3 Loss Widens On Higher R&D Expenses | 13.11.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/equillium-q3-loss-widens-on-higher-r&d-expenses-1036761573Alexandria Real Estate Equities Q3 Loss Widens | 26.10.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/alexandria-real-estate-equities-q3-loss-widens-1036667795